Pulmonary Hypertension vs. Systemic Hypertension: Key Differences in Causes, Symptoms, and Management
Pulmonary hypertension (PH) and systemic (essential) hypertension (HTN) both involve elevated blood pressure but affect different vascular beds and have distinct pathophysiology.
Pulmonary Hypertension (WHO Group 1–5)
- Definition: Mean pulmonary arterial pressure (mPAP) >20 mmHg at rest (RHC).
- Pathology: Pulmonary vascular remodeling → increased pulmonary vascular resistance (PVR) → right ventricular (RV) strain/failure.
- Causes: Idiopathic/heritable (PAH), left heart disease (Group 2), lung disease/hypoxia (Group 3), chronic thromboembolic (Group 4), multifactorial (Group 5).
- Symptoms: Exertional dyspnea (hallmark), fatigue, syncope, chest pain, peripheral edema, RV heave, loud P2.
- Diagnosis: Echo (estimated RVSP), right heart catheterization (gold standard), V/Q scan (CTEPH).
- Treatment: PAH‑specific (ERAs, PDE5i, prostacyclins, sGC stimulators); treat underlying cause for Groups 2–5; anticoagulation (CTEPH); lung transplant (end‑stage).
Systemic Hypertension
- Definition: Office BP ≥130/80 mmHg (ACC/AHA) or ≥140/90 (ESC/JNC).
- Pathology: Increased systemic vascular resistance → left ventricular hypertrophy → heart failure, stroke, CKD, CAD.
- Risk factors: Age, obesity, salt, alcohol, inactivity, genetics, renal/endocrine disorders.
- Symptoms: Often asymptomatic; severe HTN → headache, visual changes, epistaxis.
- Treatment: Lifestyle (DASH, Na⁺<2.3g, exercise, weight loss, EtOH moderation) + antihypertensives (ACEi/ARB, CCB, thiazide, β‑blocker per guidelines).
Key Distinctions
| Feature | Pulmonary Hypertension | Systemic Hypertension |
|---|---|---|
| Vascular bed | Pulmonary arteries | Systemic arteries |
| Primary ventricle affected | Right ventricle | Left ventricle |
| Common symptoms | Dyspnea, syncope, RV failure signs | Often silent; headache, vision changes |
| Diagnostic gold standard | Right heart catheterization | Ambulatory/home BP monitoring |
| Disease‑specific drugs | PAH‑targeted (ERAs, PDE5i, prostanoids) | ACEi, ARB, CCB, thiazides, etc. |
